Title |
Prolonged platelet hyperactivity after COVID‐19 infection
|
---|---|
Published in |
British Journal of Haematology, October 2023
|
DOI | 10.1111/bjh.19125 |
Pubmed ID | |
Authors |
Noriko Nara, Mie Shimizu, Masahiro Yamamoto, Tomoki Nakamizo, Azusa Hayakawa, Ken Johkura |
Abstract |
Platelet hyperactivity often occurs in patients with coronavirus disease 2019 (COVID-19). However, it remains unclear how long platelet hyperactivity lasts after the acute phase, owing to a lack of follow-up studies. To elucidate the course of platelet hyperactivity, we serially measured platelet activity in patients with COVID-19 up to 40 days after hospital admission using an easily assessable haematology analyser that semi-quantitates platelet clumps on a scattergram. Our results showed that platelet hyperactivity persisted for at least 40 days even after acute inflammation subsided in most patients with COVID-19, regardless of disease severity. Persistent platelet hyperactivity may contribute to thromboembolic complications in post-COVID-19 patients. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 16 | 9% |
Spain | 11 | 6% |
Germany | 7 | 4% |
Japan | 6 | 3% |
Australia | 6 | 3% |
Canada | 4 | 2% |
United Kingdom | 3 | 2% |
Netherlands | 3 | 2% |
Colombia | 2 | 1% |
Other | 11 | 6% |
Unknown | 111 | 62% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 162 | 90% |
Practitioners (doctors, other healthcare professionals) | 8 | 4% |
Scientists | 5 | 3% |
Science communicators (journalists, bloggers, editors) | 5 | 3% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 5 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 2 | 40% |
Professor > Associate Professor | 1 | 20% |
Other | 1 | 20% |
Unknown | 1 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Neuroscience | 2 | 40% |
Computer Science | 1 | 20% |
Medicine and Dentistry | 1 | 20% |
Unknown | 1 | 20% |